Correction to: Measuring Overall Severity of Myasthenia Gravis (MG): Evidence for the Added Value of the MG Symptoms PRO

Authors

Antoine Regnault, Modus Outcomes, A Division of THREAD, Lyon, France.
Thomas Morel, UCB Pharma SRL, Allée de la Recherche, 60, 1070, Brussels, Belgium. Thomas.Morel@ucb.com.
Christine de la Loge, PCOM Analytics, Avallon, France.
Flora Mazerolle, Modus Outcomes, A Division of THREAD, Lyon, France.
Henry J. Kaminski, Department of Neurology and Rehabilitation Medicine, George Washington University, Washington, DC, USA.
Ali A. Habib, Department of Neurology, University of California, Irvine, CA, USA.

Document Type

Journal Article

Publication Date

6-27-2023

Journal

Neurology and therapy

DOI

10.1007/s40120-023-00508-2

APA Citation

Regnault, Antoine; Morel, Thomas; de la Loge, Christine; Mazerolle, Flora; Kaminski, Henry J.; and Habib, Ali A., "Correction to: Measuring Overall Severity of Myasthenia Gravis (MG): Evidence for the Added Value of the MG Symptoms PRO" (2023). GW Authored Works. Paper 2681.
https://hsrc.himmelfarb.gwu.edu/gwhpubs/2681

Department

Neurology